KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Other financing activities (2016 - 2025)

Historic Other financing activities for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to -$137.0 million.

  • Gilead Sciences' Other financing activities fell 6707.32% to -$137.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$424.0 million, marking a year-over-year decrease of 5820.9%. This contributed to the annual value of -$281.0 million for FY2024, which is 71.68% down from last year.
  • As of Q3 2025, Gilead Sciences' Other financing activities stood at -$137.0 million, which was down 6707.32% from -$64.0 million recorded in Q2 2025.
  • In the past 5 years, Gilead Sciences' Other financing activities ranged from a high of -$6.0 million in Q2 2021 and a low of -$176.0 million during Q1 2025
  • For the 5-year period, Gilead Sciences' Other financing activities averaged around -$66.1 million, with its median value being -$47.0 million (2024).
  • Over the last 5 years, Gilead Sciences' Other financing activities had its largest YoY gain of 2142.86% in 2021, and its largest YoY loss of 70000.0% in 2021.
  • Quarter analysis of 5 years shows Gilead Sciences' Other financing activities stood at -$11.0 million in 2021, then tumbled by 109.09% to -$23.0 million in 2022, then tumbled by 47.83% to -$34.0 million in 2023, then tumbled by 38.24% to -$47.0 million in 2024, then plummeted by 191.49% to -$137.0 million in 2025.
  • Its Other financing activities was -$137.0 million in Q3 2025, compared to -$64.0 million in Q2 2025 and -$176.0 million in Q1 2025.